Obesity has emerged as one of the most pressing public health challenges globally, affecting over 650 million adults, ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and ...

The Crypto.com Showdown was full of playful banter—and that included Rory McIlroy taking a shot at Charles Barkley's weight.

The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling ...

PGA Tour star Rory McIlroy had a fun back-and-forth with Basketball Hall of Famer Charles Barkley during "The Showdown" in ...

The woman was accused of selling counterfeit versions of popular weight loss drugs, including Ozempic and Wegovy. Experts say ...

The U.S. Food and Drug Administration said on Tuesday it has sent warning letters to four companies for selling unapproved ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

LONDON — Britain's drugs cost-effectiveness watchdog NICE said on Thursday it will recommend Eli Lilly's LLY.N obesity drug ...

The drug and biotech sector saw a strong first half of 2024, driven by an increase in mergers and acquisitions (M&A), robust ...

Eli Lilly's key products, Mounjaro and Zepbound, dominate the U.S. weight loss market. Read more to see why I rate LLY stock ...

Conagra Brands will introduce an On Track label on some of its Healthy Choice ready meals to cater to users of GLP-1 drugs ...